nach oben

Herzschrittmachertherapie + Elektrophysiologie

Erschienen in:

25.04.2018 | Schwerpunkt

Orthostatic intolerance and postural tachycardia syndrome: new insights into pathophysiology and treatment

verfasst von: Mohammed Ruzieh, MD, Prof. Blair P. Grubb, MD FACC

Erschienen in: Herzschrittmachertherapie + Elektrophysiologie | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Orthostatic intolerance is characterized by symptoms of light-headedness or syncope that is provoked upon standing or in an upright posture. It is most commonly caused by postural orthostatic tachycardia syndrome (POTS) or orthostatic hypotension (OH). Its pathophysiology is complex and commonly involves abnormal autonomic nervous system regulation, autoimmunity, a hyperadrenergic state, and hypovolemia. This article reviews the pathophysiology underlying orthostatic intolerance, as well as the current treatment available.

Fedorowski A, Melander O (2013) Syndromes of orthostatic intolerance: a hiddendanger. J Intern Med 273:322–335CrossRefPubMed

Grubb BP (2008) Postural tachycardia syndrome. Circulation 117:2814–2817CrossRefPubMed

Sheldon RS, Grubb BP, Olshansky B, Shen W‑K, Calkins H, Brignole M, Raj SR, Krahn AD, Morillo CA, Stewart JM, Sutton R, Sandroni P, Friday KJ, Hachul DT, Cohen MI, Lau DH, Mayuga KA, Moak JP, Sandhu RK, Kanjwal K (2015) 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and Vasovagal syncope. Heart Rhythm 12:e41–e63CrossRefPubMedPubMedCentral

Jacob G, Costa F, Shannon JR, Robertson RM, Wathen M, Stein M, Biaggioni I, Ertl A, Black B, Robertson D (2000) The neuropathic postural tachycardia syndrome. N Engl J Med 343:1008–1014CrossRefPubMed

Peltier AC, Garland E, Raj SR, Sato K, Black B, Song Y, Wang L, Biaggioni I, Diedrich A, Robertson D (2010) Distal sudomotor findings in postural tachycardia syndrome. Clin Auton Res 20:93–99CrossRefPubMed

Schondorf R, Low PA (1993) Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology 43:132–137CrossRefPubMed

Bonyhay I, Freeman R (2004) Sympathetic nerve activity in response to hypotensive stress in the postural tachycardia syndrome. Circulation 110:3193–3198CrossRefPubMed

Jacob G, Shannon JR, Costa F, Furlan R, Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D (1999) Abnormal norepinephrine clearance and Adrenergic receptor sensitivity in idiopathic orthostatic intolerance. Circulation 99:1706–1712CrossRefPubMed

Hoeldtke RD, Dworkin GE, Gaspar SR, Israel BC (1989) Sympathotonic orthostatic hypotension. A report of four cases. Neurology 39(1):34–40CrossRefPubMed

10.

Ruzieh M, Batizy L, Dasa O, Oostra C, Grubb B (2017) The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review. Scand Cardiovasc J 5:243–247CrossRef

11.

Blitshteyn S (2010) Postural tachycardia syndrome after vaccination with Gardasil. Eur J Neurol 17:e52–e52CrossRefPubMed

12.

Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA (2000) Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic Neuropathies. N Engl J Med 343:847–855CrossRefPubMed

13.

Yu X, Stavrakis S, Hill MA, Huang S, Reim S, Li H, Khan M, Hamlett S, Cunningham MW, Kem DC (2012) Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an “autoimmune” orthostatic hypotension: receptor autoantibodies in Orthostatic hypotension. J Am Soc Hypertens 6:40–47CrossRefPubMed

14.

Gibbons CH, Freeman R (2009) Antibody titers predict clinical features of autoimmune autonomic ganglionopathy. Auton Neurosci 146:8–12CrossRefPubMed

15.

Gibbons CH, Vernino SA, Freeman R (2008) Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy. Arch Neurol 65:213–217CrossRefPubMed

16.

Raj SR, Biaggioni I, Yamhure PC, Black BK, Paranjape SY, Byrne DW, Robertson D (2005) Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation 111:1574–1582CrossRefPubMed

17.

Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D (2000) Orthostatic Intolerance and Tachycardia Associated with Norepinephrine-Transporter Deficiency. N Engl J Med 342:541–549CrossRefPubMed

18.

Streeten DP, Kerr C, Kerr L, Prior J, Dalakos T (1972) Hyperbradykininism: a new orthostatic syndrome. Lancet 300:1048–1053CrossRef

19.

Shibao C, Arzubiaga C, Roberts LJ, Raj S, Black B, Harris P, Biaggioni I (2005) Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension 45:385–390CrossRefPubMed

20.

Fu Q, VanGundy TB, Galbreath MM, Shibata S, Jain M, Hastings JL, Bhella PS, Levine BD (2010) Cardiac origins of the postural orthostatic tachycardia syndrome. J Am Coll Cardiol 55:2858–2868CrossRefPubMedPubMedCentral

21.

Jansen RM, Lipsitz LA (1995) Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med 122:286–295CrossRefPubMed

22.

Potter JF, Heseltine D, Hartley G, Matthews J, Macdonald IA, James OFW (1989) Effects of meal composition on the postprandial blood pressure, catecholamine and insulin changes in elderly subjects. Clin Sci 77:265–272CrossRefPubMed

23.

Raj SR (2013) Postural Tachycardia Syndrome (POTS). Circulation 127:2336–2342CrossRefPubMedPubMedCentral

24.

Ruzieh M, Baugh A, Dasa O, Parker RL, Perrault JT, Renno A, Karabin BL, Grubb B (2017) Effects of intermittent intravenous saline infusions in patients with medication—refractory postural tachycardia syndrome. J Interv Cardiac Electrophysiol 48:255–260CrossRef

25.

Jacob G, Shannon JR, Black B, Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D (1997) Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation 96:575–580CrossRefPubMed

26.

Kaufmann H, Freeman R, Biaggioni I, Low P, Pedder S, Hewitt LA, Mauney J, Feirtag M, Mathias CJ (2014) Droxidopa for neurogenic orthostatic hypotension. A randomized, placebo-controlled, phase 3 trial. Neurology 83:328–335CrossRefPubMedPubMedCentral

27.

Ruzieh M, Dasa O, Pacenta A, Karabin B, Grubb B (2017) Droxidopa in the treatment of postural orthostatic tachycardia syndrome. Am J Ther 24:e157–e161CrossRefPubMed

28.

Raj SR, Black BK, Biaggioni I, Paranjape SY, Ramirez M, Dupont WD, Robertson D (2009) Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome. Less is more. Circulation 120:725–734CrossRefPubMedPubMedCentral

29.

Ruzieh M, Sirianni N, Ammari Z, Dasa O, Alhazmi L, Karabin B, Grubb B (2017) Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience. Pacing Clin Electrophysiol 40:1242–1245CrossRefPubMed

30.

Gaffney FA, Lane LB, Pettinger W, Blomqvist CG (1983) Effects of long-term clonidine administration on the hemodynamic and neuroendocrine postural responses of patients with dysautonomia. Chest 83:436–438CrossRefPubMed

31.

Kanjwal K, Karabin B, Sheikh M, Elmer L, Kanjwal Y, Saeed B, Grubb BP (2011) Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience. Pacing Clin Electrophysiol 34:750–755CrossRefPubMed

32.

Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB, Freedman RA, Hlatky MA, Naccarelli GV, Saksena S, Schlant RC, Silka MJ (1998) ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on pacemaker implantation)</i>. Circulation 97:1325–1335CrossRefPubMed

Titel: Orthostatic intolerance and postural tachycardia syndrome: new insights into pathophysiology and treatment
verfasst von: Mohammed Ruzieh, MD
Prof. Blair P. Grubb, MD FACC
Publikationsdatum: 25.04.2018
Verlag: Springer Medizin
Erschienen in: Herzschrittmachertherapie + Elektrophysiologie / Ausgabe 2/2018
Print ISSN: 0938-7412
Elektronische ISSN: 1435-1544
DOI: https://doi.org/10.1007/s00399-018-0563-1

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Orthostatic intolerance and postural tachycardia syndrome: new insights into pathophysiology and treatment

Abstract

Neu im Fachgebiet Kardiologie

Die „Zehn Gebote“ des Endokarditis-Managements

Strenge Blutdruckeinstellung lohnt auch im Alter noch

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

Frauen bekommen seltener eine intensive Statintherapie

Update Kardiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

Tipps für die Anamnese bei Patienten mit Synkope

Psychogene nichtepileptische Anfälle

Fahreignung bei Synkope

Synkopen und Ionenkanalerkrankungen

Benötigen wir Syncope Units?

Reise des S‑ICD zur First-Line-Therapie

Neu im Fachgebiet Kardiologie

Die „Zehn Gebote“ des Endokarditis-Managements

Strenge Blutdruckeinstellung lohnt auch im Alter noch

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

Frauen bekommen seltener eine intensive Statintherapie

Update Kardiologie